We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.25%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$10B
AUM Growth
+$477M
Cap. Flow
+$229M
Cap. Flow %
2.28%
Top 10 Hldgs %
15.52%
Holding
1,590
New
33
Increased
385
Reduced
1,013
Closed
155

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$14.4M
2
VAL
Valspar
VAL
+$10M
3
MMM icon
3M
MMM
+$9.22M
4
GS icon
Goldman Sachs
GS
+$8.07M
5
MCD icon
McDonald's
MCD
+$8.07M

Sector Composition

Rank Sector Weight
1 Financials 15.02%
2 Healthcare 14.76%
3 Technology 13.2%
4 Consumer Staples 11.05%
5 Industrials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MACK
1401
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$98K ﹤0.01%
10,081
-552
-5% -$11.3K
XBIT icon
1402
XBiotech
XBIT
$69.2M
$93K ﹤0.01%
19,823
+485
+3% +$4.65K
FOMX
1403
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$89K ﹤0.01%
19,108
-741
-4% -$3.31K
HLX icon
1404
Helix Energy Solutions
HLX
$1.44B
$82K ﹤0.01%
14,477
-4,644
-24% -$28.1K
FIT
1405
DELISTED
Fitbit, Inc. Class A common stock
FIT
$82K ﹤0.01%
+15,436
New +$85.6K
FCH
1406
DELISTED
Felcor Lodging Trust
FCH
$82K ﹤0.01%
11,391
-4,307
-27% -$31.9K
TRVN
1407
DELISTED
Trevena, Inc.
TRVN
$80K ﹤0.01%
56
+3
+6% +$5.51K
TXMD icon
1408
TherapeuticsMD
TXMD
$23.8M
$73K ﹤0.01%
276
-70
-20% -$17.5K
LSCC icon
1409
Lattice Semiconductor
LSCC
$18.5B
$72K ﹤0.01%
10,849
-2,963
-21% -$20.3K
TCRT icon
1410
Alaunos Therapeutics
TCRT
$4.57M
$72K ﹤0.01%
77
-16
-17% -$15.7K
DNR
1411
DELISTED
Denbury Resources, Inc.
DNR
$70K ﹤0.01%
45,875
-10,584
-19% -$19.8K
MTW icon
1412
Manitowoc
MTW
$501M
$68K ﹤0.01%
2,817
-844
-23% -$19.7K
CSR
1413
Centerspace
CSR
$936M
$67K ﹤0.01%
1,077
-318
-23% -$19.2K
OMED
1414
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$64K ﹤0.01%
19,312
-2,928
-13% -$12.1K
ARWR icon
1415
Arrowhead Research
ARWR
$12.3B
$62K ﹤0.01%
38,380
-9,274
-19% -$15K
STNG icon
1416
Scorpio Tankers
STNG
$3.94B
$58K ﹤0.01%
1,457
-425
-23% -$17.2K
FMSA
1417
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$53K ﹤0.01%
13,708
+3,247
+31% +$16.8K
KLDX
1418
DELISTED
KLONDEX MINES LTD
KLDX
$52K ﹤0.01%
+15,544
New +$53.7K
ISEE
1419
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$47K ﹤0.01%
18,402
-4,220
-19% -$11.5K
ARLZ
1420
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$46K ﹤0.01%
33,798
-1,122
-3% -$1.62K
ASNA
1421
DELISTED
Ascena Retail Group, Inc.
ASNA
$42K ﹤0.01%
971
-340
-26% -$19.6K
ATRS
1422
DELISTED
Antares Pharma, Inc.
ATRS
$41K ﹤0.01%
+12,695
New +$36K
PLUG icon
1423
Plug Power
PLUG
$3.08B
$40K ﹤0.01%
19,743
-2,272
-10% -$4.76K
TTI icon
1424
TETRA Technologies
TTI
$1.29B
$33K ﹤0.01%
11,847
-3,919
-25% -$13K
CLNE icon
1425
Clean Energy Fuels
CLNE
$469M
$31K ﹤0.01%
12,061
+1,075
+10% +$2.66K

Similar funds

ProShare Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, ProShare Advisors held 1,590 positions worth $10B, up 5% from $9.56B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

ProShare Advisors's Q2 2017 filing shows 33 new, 385 increased, 1,013 reduced and 155 closed positions. Its largest new stake was Westwood Holdings Group: 133,198 shares worth $7.55M. The largest sale was Yahoo Inc, an estimated $14.4M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Technology.

  • ProShare Advisors's largest Q2 2017 buy was Westwood Holdings Group: 133,198 shares worth $7.55M.
  • ProShare Advisors added most to Apple in Q2 2017, an estimated $44.7M increase.
  • ProShare Advisors's biggest Q2 2017 reduction was 3M, cutting an estimated $9.22M.
  • ProShare Advisors fully exited Yahoo Inc in Q2 2017, selling an estimated $14.4M.
  • ProShare Advisors's ten largest holdings make up 16% of its $10B portfolio in Q2 2017.
  • ProShare Advisors opened 33 new positions and closed 155 in Q2 2017.
  • ProShare Advisors's portfolio value rose 5% quarter-over-quarter to $10B.

Based on ProShare Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.